Crohn's disease and ulcerative colitis, two inflammatory bowel diseases (IBD), need lifelong management. A smooth transition between pediatric and adult IBD care is crucial. This program discusses what is needed for a successful changeover and improved quality of life in young adulthood.
Many patients with mild to moderate Crohn's disease might benefit from a novel therapy discovered by a research team at Virginia Tech. Scientists at the university's Nutritional Immunology and Molecular Medicine Laboratory (NIMML) have announced a link between the use of conjugated linoleic acid (CLA) and marked improvement in half the subjects who took it.